DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kaletra (Lopinavir / Ritonavir) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (306)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kaletra (Lopinavir / Ritonavir) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 306   Next >>

Possible Kaletra side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Hepatic Function Abnormal, Cardiac Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Invirase
    Dosage: divided dose requency u
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-26

Isentress
    Dosage: divided dose frequency unknown
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-07-31
    End date: 2011-08-07

Kaletra
    Dosage: divided dose frequency unknown
    Administration route: Oral
    Start date: 2004-08-31
    End date: 2006-09-21

Kaletra
    Dosage: divided dose frequency unknown
    Administration route: Oral
    Start date: 2006-10-26
    End date: 2011-07-07

Kaletra
    Dosage: divided dose frequency unknown
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-03
    End date: 2004-08-04

Other drugs received by patient: Halcion



Possible Kaletra side effects in male

Reported by a physician from Chile on 2012-08-24

Patient: male, weighing 87.0 kg (191.4 pounds)

Reactions: Asthmatic Crisis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Lamivudine (Epivir Hbv); Escitalopram; Valproic Acid; Flemar; Clotiazepam; Acyclovir



Possible Kaletra side effects in female

Reported by a physician from France on 2012-08-24

Patient: female

Reactions: Cholestasis of Pregnancy, Maternal Exposure During Pregnancy, Adverse Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2012-03-05
    End date: 2012-03-19

Combivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2012-03-19
    End date: 2012-05-24

Kaletra
    Dosage: 2tab twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2012-03-19
    End date: 2012-05-24



Possible Kaletra side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male, weighing 2.6 kg (5.7 pounds)

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Other drugs received by patient: Combivir; Zidovudine; Darunavir Ethanolate



Possible Kaletra side effects in female

Reported by a physician from Israel on 2012-08-23

Patient: female

Reactions: Caesarean Section

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Combivir



Possible Kaletra side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Diabetes Mellitus, Hypertriglyceridaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Epivir
    Dosage: 150 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-09-16
    End date: 2006-02-28

Epivir
    Dosage: 150 mg, bid
    Administration route: Oral
    Start date: 2008-12-16

Intelence
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-02-11

Isentress
    Dosage: 800 mg divided dose frequency u
    Administration route: Oral
    Start date: 2008-08-05

Kaletra
    Dosage: 4 df
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-04
    End date: 2008-01-08

Prezista
    Dosage: 1200 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-09
    End date: 2008-05-01

Truvada
    Dosage: 1 df, unk
    Administration route: Oral
    Start date: 2008-08-05
    End date: 2008-12-15

Truvada
    Dosage: 1df
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-07-04
    End date: 2008-05-01

Zerit
    Dosage: 60 mg divided dose frequency u
    Administration route: Oral
    Start date: 2008-12-16
    End date: 2009-02-10

Zerit
    Dosage: 80 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-09-16
    End date: 2006-02-28

Other drugs received by patient: Rhythmy



Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-08-22

Patient: male

Reactions: Hypophosphataemia, Diarrhoea, Cardiac Failure, Lactic Acidosis, Liver Disorder

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abacavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-08-31
    End date: 2006-09-21

Didanosine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-03
    End date: 2004-08-04

Didanosine
    Administration route: Oral
    Start date: 2004-08-31
    End date: 2006-09-21

Didanosine
    Administration route: Oral
    Start date: 2006-10-26

Isentress
    Dosage: 800mg daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-08-07

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-03
    End date: 2004-08-04

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-26
    End date: 2011-08-07

Kaletra
    Administration route: Oral
    Start date: 2004-08-31
    End date: 2006-09-21

Stavudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-04-01
    End date: 2004-08-04

Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-08-31
    End date: 2006-09-21

Other drugs received by patient: Glycyron; Saquinavir; Allopurinol; Bifidobacterium; Loperamide HCL; Allopurinol



Possible Kaletra side effects in female

Reported by a pharmacist from France on 2012-08-20

Patient: female

Reactions: Cholestasis of Pregnancy, Gestational Diabetes, Adverse Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-19
    End date: 2012-05-24

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-19
    End date: 2012-05-24

Other drugs received by patient: Isentress; Truvada



Possible Kaletra side effects in female

Reported by a physician from Russian Federation on 2012-08-17

Patient: female

Reactions: Umbilical Cord Abnormality, Anaemia, Placental Disorder, PRE-Eclampsia, Enterocolitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epivir
    Indication: Product Used FOR Unknown Indication

Kaletra
    Indication: HIV Infection
    Start date: 2012-02-17

Kaletra

Nikavir
    Indication: HIV Infection

Other drugs received by patient: Valcit; Elevit; Folic Acid; Kipferon; Erythromycin; Combivir; Wobenzym; Hexicon Suppositories; Trichopol; Acyclovir



Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-08-17

Patient: male

Reactions: Rhabdomyolysis, Dyspnoea, Hepatic Failure, Lactic Acidosis, Acidosis, Fall, Haematemesis, Haematochezia, Multi-Organ Failure, Spinal Compression Fracture, Fractured Ischium, Melaena, Renal Failure Acute, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra
    Dosage: 4 dosage forms daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-09-12
    End date: 2011-01-14

Sulfamethoxazole and Trimethoprim
    Indication: Prophylaxis

Sulfamethoxazole and Trimethoprim
    Administration route: Oral
    Indication: Pneumocystis Jiroveci Pneumonia
    End date: 2011-01-14

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-04-27
    End date: 2011-01-14

Other drugs received by patient: Zerit; Lamivudine



Possible Kaletra side effects in male

Reported by a physician from France on 2012-08-16

Patient: male

Reactions: Agitation, Urinary Incontinence, Coma, Coma Scale Abnormal, Pyrexia, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, General Physical Health Deterioration, Encephalopathy, Faecal Incontinence, Convulsion, Respiratory Tract Congestion, Apathy, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Hyponatraemia, Cerebral Atrophy, White Blood Cell Disorder, Renal Failure, Hypoproteinaemia, Diarrhoea, Brain Abscess, Heart Rate Increased, Encephalitic Infection, Heart Sounds Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: df 10mg/ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Amikacin
    Dosage: 900 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Bactrim
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Cernevit-12
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Clarithromycin
    Dosage: df 50mg/ml
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Folic Acid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-01

Kaletra
    Dosage: df 80/20 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Myambutol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Nefopam
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Olanzapine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Perikabiven (Parenteral Nutrition)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Potassium Chloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Prazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Rifabutin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Viramune
    Indication: HIV Infection
    Start date: 2012-03-01
    End date: 2012-05-01

Other drugs received by patient: Propofol; Adavat



Possible Kaletra side effects in male

Reported by a physician from France on 2012-08-15

Patient: male

Reactions: Agitation, Urinary Incontinence, Coma, Pyrexia, Coma Scale Abnormal, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, Encephalopathy, Faecal Incontinence, General Physical Health Deterioration, Convulsion, Apathy, Respiratory Tract Congestion, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Cerebral Atrophy, Hyponatraemia, Renal Failure, White Blood Cell Disorder, Diarrhoea, Hypoproteinaemia, Heart Rate Increased, Brain Abscess, Encephalitic Infection, Heart Sounds Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: df 10mg/ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Amikacin
    Dosage: 900 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Bactrim
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Cernevit-12
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Clarithromycin
    Dosage: df 50mg/ml
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Folic Acid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-01

Kaletra
    Dosage: df 80/20 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Myambutol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Nefopam
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Olanzapine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Perikabiven (Parenteral Nutrition)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Potassium Chloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Prazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Rifabutin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Viramune
    Indication: HIV Infection
    Start date: 2012-03-01
    End date: 2012-05-01

Other drugs received by patient: Adavat; Propofol



Possible Kaletra side effects in male

Reported by a consumer/non-health professional from Canada on 2012-08-13

Patient: male

Reactions: Weight Decreased, Pneumonia, Tuberculosis, Pleural Effusion, Brain Neoplasm

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra



Possible Kaletra side effects in female

Reported by a consumer/non-health professional from Australia on 2012-08-10

Patient: female

Reactions: Pneumonia Aspiration, Diarrhoea, Intestinal Prolapse, Pneumothorax, Impaired Gastric Emptying, Gastric Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Indication: HIV Infection
    Start date: 2010-06-01

Truvada
    Indication: Product Used FOR Unknown Indication



Possible Kaletra side effects in male

Reported by a physician from Germany on 2012-08-09

Patient: male

Reactions: Suicidal Ideation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Novaminosulfon; Diclofenac; Isentress



Possible Kaletra side effects in male

Reported by a physician from United States on 2012-08-09

Patient: male, weighing 2.6 kg (5.7 pounds)

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Other drugs received by patient: Darunavir Ethanolate; Zidovudine; Combivir



Possible Kaletra side effects in 42 year old male

Reported by a physician from Germany on 2012-08-08

Patient: 42 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: Meniscal Degeneration, Arthralgia, Chondrocalcinosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Isentress; Cialis; Enalapril Maleate



Possible Kaletra side effects in male

Reported by a physician from United States on 2012-08-08

Patient: male, weighing 2.1 kg (4.6 pounds)

Reactions: Atrial Septal Defect, Congenital Anaemia, Cardiac Murmur, Dysmorphism, Premature Baby, Foetal Exposure During Pregnancy, Jaundice Neonatal, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-09-22

Kaletra
    Dosage: 4tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-09-22

Other drugs received by patient: Metronidazole



Possible Kaletra side effects in 9 year old female

Reported by a consumer/non-health professional from Ireland on 2012-08-08

Patient: 9 year old female

Reactions: Regurgitation, Aphagia, Malaise, Nausea, Insomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epivir
    Indication: Product Used FOR Unknown Indication

Kaletra
    Indication: Product Used FOR Unknown Indication

Maxolon
    Indication: Product Used FOR Unknown Indication

Motilium
    Indication: Product Used FOR Unknown Indication

Retrovir
    Indication: Product Used FOR Unknown Indication



Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-08-06

Patient: male

Reactions: Colonic Polyp, Iron Deficiency Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Allopurinol; Candesartan Cilexetil; Raltegravir; Tenofovir Disoproxil Fumarate



Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-08-06

Patient: male

Reactions: Rhabdomyolysis, Dyspnoea, Hepatic Failure, Lactic Acidosis, Acidosis, Fall, Haematemesis, Multi-Organ Failure, Haematochezia, Spinal Compression Fracture, Fractured Ischium, Melaena, Hepatic Cirrhosis, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra
    Dosage: 4 dosage forms daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-09-12
    End date: 2011-01-14

Sulfamethoxazole and Trimethoprim
    Indication: Prophylaxis

Sulfamethoxazole and Trimethoprim
    Administration route: Oral
    Indication: Pneumocystis Jiroveci Pneumonia
    End date: 2011-01-14

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-04-27
    End date: 2011-01-14

Other drugs received by patient: Lamivudine; Zerit



Possible Kaletra side effects in 53 year old male

Reported by a physician from Japan on 2012-08-06

Patient: 53 year old male

Reactions: Pyrexia, Mycobacterium Avium Complex Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Raltegravir; Fosamprenavir Calcium; Ritonavir; Abacavir Sulfate / Lamivudine



Possible Kaletra side effects in 40 year old female

Reported by a physician from Japan on 2012-08-03

Patient: 40 year old female

Reactions: Abortion Induced

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Raltegravir; Lamivudine + Zidovudine; Emtricitabine / Tenofovir Disoproxil Fumarate



Possible Kaletra side effects in male

Reported by a physician from Japan on 2012-08-02

Patient: male

Reactions: Hyperlipidaemia, Oesophageal Candidiasis, Syphilis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Dosage: 4 dosage forms daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-11-27

Kaletra
    Dosage: 6 dosage form
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-01
    End date: 2006-11-26

Truvada
    Start date: 2011-08-08

Truvada
    Dosage: 1 dosage form daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-04-29

Zerit
    Dosage: 60 mg daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-01
    End date: 2008-01-01

Zerit
    Dosage: 60 mg daily
    Administration route: Oral
    Start date: 2009-04-29
    End date: 2011-08-07

Other drugs received by patient: Tenofovir Disoproxil Fumarate; Lamivudine; Lamivudine; Tenofovir Disoproxil Fumarate



Possible Kaletra side effects in male

Reported by a physician from Chile on 2012-07-31

Patient: male, weighing 87.0 kg (191.4 pounds)

Reactions: Asthmatic Crisis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Lamivudine (Epivir Hbv)



Possible Kaletra side effects in male

Reported by a physician from United States on 2012-07-30

Patient: male, weighing 2.1 kg (4.6 pounds)

Reactions: Atrial Septal Defect, Cardiac Murmur, Dysmorphism, Congenital Anaemia, Premature Baby, Foetal Exposure During Pregnancy, Jaundice Neonatal, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-09-22

Kaletra
    Dosage: 4tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-09-22

Other drugs received by patient: Metronidazole



Possible Kaletra side effects in 9 year old female

Reported by a consumer/non-health professional from Ireland on 2012-07-27

Patient: 9 year old female

Reactions: Poor Quality Sleep, Malaise, Nausea, Hypophagia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
ALL Other Therapeutic Products
    Dosage: twice a day
    Indication: Product Used FOR Unknown Indication

Epivir
    Dosage: twice a day
    Indication: Product Used FOR Unknown Indication

Kaletra
    Dosage: twice a day
    Indication: Product Used FOR Unknown Indication

Maxolon
    Dosage: twice a day
    Indication: Product Used FOR Unknown Indication

Retrovir
    Dosage: twice a day
    Indication: Product Used FOR Unknown Indication



Possible Kaletra side effects in 9 year old female

Reported by a consumer/non-health professional from Ireland on 2012-07-27

Patient: 9 year old female

Reactions: Aphagia, Regurgitation, Malaise, Nausea, Insomnia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epivir
    Indication: Product Used FOR Unknown Indication

Kaletra
    Indication: Product Used FOR Unknown Indication

Maxolon
    Indication: Product Used FOR Unknown Indication

Motilium
    Indication: Product Used FOR Unknown Indication

Retrovir
    Indication: Product Used FOR Unknown Indication



Possible Kaletra side effects in female

Reported by a physician from Canada on 2012-07-26

Patient: female

Reactions: Immature Respiratory System, Premature Baby, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Zidovudine; Septra



Possible Kaletra side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: female

Reactions: Dysphagia, Respiratory Disorder, Foetal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Dosage: 4tab per day
    Indication: HIV Infection
    Start date: 2009-08-01

Lamivudine + Zidovudine
    Dosage: 2tab per day
    Indication: HIV Infection
    Start date: 2009-08-01

Retrovir
    Indication: Antiviral Prophylaxis
    Start date: 2010-04-02
    End date: 2010-04-02



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017